Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

DIEP Flap Breast Reconstruction Complication Rate in Previously Irradiated Internal Mammary Nodes.

Shechter S, Arad E, Inbal A, Friedman O, Gur E, Barnea Y.

J Reconstr Microsurg. 2018 Jul;34(6):399-403. doi: 10.1055/s-0038-1625986. Epub 2018 Apr 19.

PMID:
29672777
2.

Identification of novel antivirals inhibiting recognition of Venezuelan equine encephalitis virus capsid protein by the Importin α/β1 heterodimer through high-throughput screening.

Thomas DR, Lundberg L, Pinkham C, Shechter S, DeBono A, Baell J, Wagstaff KM, Hick CA, Kehn-Hall K, Jans DA.

Antiviral Res. 2018 Mar;151:8-19. doi: 10.1016/j.antiviral.2018.01.007. Epub 2018 Jan 11.

3.

Novel inhibitors targeting Venezuelan equine encephalitis virus capsid protein identified using In Silico Structure-Based-Drug-Design.

Shechter S, Thomas DR, Lundberg L, Pinkham C, Lin SC, Wagstaff KM, Debono A, Kehn-Hall K, Jans DA.

Sci Rep. 2017 Dec 18;7(1):17705. doi: 10.1038/s41598-017-17672-9.

4.

Cost-effectiveness Analysis of Vascular Access Referral Policies in CKD.

Shechter SM, Chandler T, Skandari MR, Zalunardo N.

Am J Kidney Dis. 2017 Sep;70(3):368-376. doi: 10.1053/j.ajkd.2017.04.020. Epub 2017 Jun 7.

PMID:
28599902
5.

Deciphering mechanisms of drug sensitivity and resistance to Selective Inhibitor of Nuclear Export (SINE) compounds.

Crochiere M, Kashyap T, Kalid O, Shechter S, Klebanov B, Senapedis W, Saint-Martin JR, Landesman Y.

BMC Cancer. 2015 Nov 17;15:910. doi: 10.1186/s12885-015-1790-z.

6.

Forecasting the effect of physician assistants in a pediatric ED.

Doan Q, Hall W, Shechter S, Kissoon N, Sheps S, Singer J, Wong H, Johnson D.

JAAPA. 2014 Aug;27(8):35-41. doi: 10.1097/01.JAA.0000451860.95151.e1.

PMID:
25054792
7.

RhoB controls coordination of adult angiogenesis and lymphangiogenesis following injury by regulating VEZF1-mediated transcription.

Gerald D, Adini I, Shechter S, Perruzzi C, Varnau J, Hopkins B, Kazerounian S, Kurschat P, Blachon S, Khedkar S, Bagchi M, Sherris D, Prendergast GC, Klagsbrun M, Stuhlmann H, Rigby AC, Nagy JA, Benjamin LE.

Nat Commun. 2013;4:2824. doi: 10.1038/ncomms3824.

8.

Using operations research to plan improvement of the transport of critically ill patients.

Chen J, Awasthi A, Shechter S, Atkins D, Lemke L, Fisher L, Dodek P.

Prehosp Emerg Care. 2013 Oct-Dec;17(4):466-74. doi: 10.3109/10903127.2013.811561.

PMID:
23992200
9.

Timing of arteriovenous fistula creation in patients With CKD: a decision analysis.

Shechter SM, Skandari MR, Zalunardo N.

Am J Kidney Dis. 2014 Jan;63(1):95-103. doi: 10.1053/j.ajkd.2013.06.021. Epub 2013 Aug 24.

PMID:
23978336
10.

State-space size considerations for disease-progression models.

Regnier ED, Shechter SM.

Stat Med. 2013 Sep 30;32(22):3862-80. doi: 10.1002/sim.5808. Epub 2013 Apr 23.

PMID:
23609629
11.

RhoB differentially controls Akt function in tumor cells and stromal endothelial cells during breast tumorigenesis.

Kazerounian S, Gerald D, Huang M, Chin YR, Udayakumar D, Zheng N, O'Donnell RK, Perruzzi C, Mangiante L, Pourat J, Phung TL, Bravo-Nuevo A, Shechter S, McNamara S, Duhadaway JB, Kocher ON, Brown LF, Toker A, Prendergast GC, Benjamin LE.

Cancer Res. 2013 Jan 1;73(1):50-61. doi: 10.1158/0008-5472.CAN-11-3055. Epub 2012 Nov 7.

12.

Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors.

Kalid O, Toledo Warshaviak D, Shechter S, Sherman W, Shacham S.

J Comput Aided Mol Des. 2012 Nov;26(11):1217-28. doi: 10.1007/s10822-012-9611-9. Epub 2012 Sep 30.

PMID:
23053738
13.

Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia.

Lapalombella R, Sun Q, Williams K, Tangeman L, Jha S, Zhong Y, Goettl V, Mahoney E, Berglund C, Gupta S, Farmer A, Mani R, Johnson AJ, Lucas D, Mo X, Daelemans D, Sandanayaka V, Shechter S, McCauley D, Shacham S, Kauffman M, Chook YM, Byrd JC.

Blood. 2012 Nov 29;120(23):4621-34. doi: 10.1182/blood-2012-05-429506. Epub 2012 Oct 3.

14.

Identification of the PDZ3 domain of the adaptor protein PDZK1 as a second, physiologically functional binding site for the C terminus of the high density lipoprotein receptor scavenger receptor class B type I.

Kocher O, Birrane G, Yesilaltay A, Shechter S, Pal R, Daniels K, Krieger M.

J Biol Chem. 2011 Jul 15;286(28):25171-86. doi: 10.1074/jbc.M111.242362. Epub 2011 May 23.

15.

Treatment evolution and new standards of care: implications for cost-effectiveness analysis.

Shechter SM.

Med Decis Making. 2011 Jan-Feb;31(1):35-42. doi: 10.1177/0272989X10364849. Epub 2010 Mar 30.

PMID:
20354228
16.

Akt promotes endocardial-mesenchyme transition.

Meadows KN, Iyer S, Stevens MV, Wang D, Shechter S, Perruzzi C, Camenisch TD, Benjamin LE.

J Angiogenes Res. 2009 Sep 21;1:2. doi: 10.1186/2040-2384-1-2.

17.

The use of discrete-event simulation modelling to improve radiation therapy planning processes.

Werker G, Sauré A, French J, Shechter S.

Radiother Oncol. 2009 Jul;92(1):76-82. doi: 10.1016/j.radonc.2009.03.012. Epub 2009 Apr 6.

PMID:
19356818
18.

Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model.

Braithwaite RS, Roberts MS, Chang CC, Goetz MB, Gibert CL, Rodriguez-Barradas MC, Shechter S, Schaefer A, Nucifora K, Koppenhaver R, Justice AC.

Ann Intern Med. 2008 Feb 5;148(3):178-85.

19.

Endothelial Akt signaling is rate-limiting for rapamycin inhibition of mouse mammary tumor progression.

Phung TL, Eyiah-Mensah G, O'Donnell RK, Bieniek R, Shechter S, Walsh K, Kuperwasser C, Benjamin LE.

Cancer Res. 2007 Jun 1;67(11):5070-5. Erratum in: Cancer Res. 2007 Jul 1;67(13):6528.

20.

Estimating the rate of accumulating drug resistance mutations in the HIV genome.

Braithwaite RS, Shechter S, Chang CC, Schaefer A, Roberts MS.

Value Health. 2007 May-Jun;10(3):204-13.

21.

Estimating the impact of alcohol consumption on survival for HIV+ individuals.

Braithwaite RS, Conigliaro J, Roberts MS, Shechter S, Schaefer A, McGinnis K, Rodriguez MC, Rabeneck L, Bryant K, Justice AC.

AIDS Care. 2007 Apr;19(4):459-66.

22.

Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation.

Braithwaite RS, Shechter S, Roberts MS, Schaefer A, Bangsberg DR, Harrigan PR, Justice AC.

J Antimicrob Chemother. 2006 Nov;58(5):1036-43. Epub 2006 Oct 5. Erratum in: J Antimicrob Chemother. 2007 Apr;59(4):821.

PMID:
17023498
23.

Increasing the efficiency of Monte Carlo cohort simulations with variance reduction techniques.

Shechter SM, Schaefer AJ, Braithwaite RS, Roberts MS.

Med Decis Making. 2006 Sep-Oct;26(5):550-3.

PMID:
16997930
24.

Incorporating biological natural history in simulation models: empirical estimates of the progression of end-stage liver disease.

Alagoz O, Bryce CL, Shechter S, Schaefer A, Chang CC, Angus DC, Roberts MS.

Med Decis Making. 2005 Nov-Dec;25(6):620-32.

PMID:
16282213
25.

A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process.

Shechter SM, Bryce CL, Alagoz O, Kreke JE, Stahl JE, Schaefer AJ, Angus DC, Roberts MS.

Med Decis Making. 2005 Mar-Apr;25(2):199-209.

PMID:
15800304
26.

A methodological framework for optimally reorganizing liver transplant regions.

Stahl JE, Kong N, Shechter SM, Schaefer AJ, Roberts MS.

Med Decis Making. 2005 Jan-Feb;25(1):35-46.

PMID:
15673580
27.

Characteristics of the flux dimension cue in apparent motion correspondence.

Shechter S, Hochstein S.

Spat Vis. 1992;6(1):11-24.

PMID:
1536827
28.
29.

Gender differences in apparent motion perception.

Shechter S, Hillman P, Hochstein S, Shapley RM.

Perception. 1991;20(3):307-14.

PMID:
1762873
30.

Prenatal sonographic appearance and subsequent management of a fetus with oromandibular limb hypogenesis syndrome associated with pulmonary hypoplasia.

Shechter SA, Sherer DM, Geilfuss CJ, Metlay LA, Woods JR Jr.

J Clin Ultrasound. 1990 Oct;18(8):661-5. No abstract available.

PMID:
2172315
31.

On and off pathway contributions to apparent motion perception.

Shechter S, Hochstein S.

Vision Res. 1990;30(8):1189-204.

PMID:
2402886
32.

Size, flux and luminance effects in the apparent motion correspondence process.

Shechter S, Hochstein S.

Vision Res. 1989;29(5):579-91.

PMID:
2603395
33.

Shape similarity and distance disparity as apparent motion correspondence cues.

Shechter S, Hochstein S, Hillman P.

Vision Res. 1988;28(9):1013-21.

PMID:
3254644
34.

Overshadowing of responding on ratio and interval schedules by an independent predictor of reinforcement.

Dickinson A, Peters RC, Shechter S.

Behav Processes. 1984 Jul;9(4):421-9. doi: 10.1016/0376-6357(84)90027-5.

PMID:
24924087

Supplemental Content

Loading ...
Support Center